The Company believes it can discover a stable of n
Post# of 30025
Posted On: 08/15/2014 9:54:35 PM
The Company believes it can discover a stable of novel MANF-like proteins using its proprietary PhenoGuard platform technology. PhenoGuard was originally developed in the Neurotrophic Factors Group at the National Institute of Neurological Disorders and Stroke (NINDS) in Bethesda, Maryland.
http://www.biospace.com/News/amarantus-biosci...-of/280919
http://finance.yahoo.com/news/amarantus-biosc...00746.html
http://www.biospace.com/News/amarantus-biosci...-of/280919
http://finance.yahoo.com/news/amarantus-biosc...00746.html
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼